J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.81 CNY 1.4% Market Closed
Market Cap: 25.7B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Jafron Biomedical Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jafron Biomedical Co Ltd
Cost of Revenue Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
J
Jafron Biomedical Co Ltd
SZSE:300529
Cost of Revenue
-ÂĄ518.3m
CAGR 3-Years
-12%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cost of Revenue
-ÂĄ486.1m
CAGR 3-Years
-51%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cost of Revenue
-ÂĄ3.7B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
-14%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cost of Revenue
-ÂĄ12.8B
CAGR 3-Years
-15%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cost of Revenue
-ÂĄ2.6B
CAGR 3-Years
13%
CAGR 5-Years
-5%
CAGR 10-Years
-17%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cost of Revenue
-ÂĄ5.9B
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jafron Biomedical Co Ltd's Cost of Revenue?
Cost of Revenue
-518.3m CNY

Based on the financial report for Jun 30, 2024, Jafron Biomedical Co Ltd's Cost of Revenue amounts to -518.3m CNY.

What is Jafron Biomedical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-21%

Over the last year, the Cost of Revenue growth was -25%. The average annual Cost of Revenue growth rates for Jafron Biomedical Co Ltd have been -12% over the past three years , -21% over the past five years .

Back to Top